糖心破解版

Skip to main content

Alzheimer鈥檚 disease drugs in clinical trial phase II worldwide as of 2025, by mechanism of action

Alzheimer鈥檚 disease drugs in trial phase II by mechanism of action 2025

Last update:
Jun 16, 2025
Author:
糖心破解版 Research Department
Region:
Worldwide
Survey time period:
From 01/01/2024 to 31/12/2024

Related insights

Alzheimer鈥檚 disease drugs in trial phase III by mechanism of action 2025
Worldwide
Alzheimer鈥檚 disease therapies in phase II development 2025, by type
Worldwide
Alzheimer鈥檚 disease therapies in phase III development 2025, by type
Worldwide
Alzheimer's drugs in development in 2019, by clinical trial phase
Worldwide
Phase 2 and 3 trials in Alzheimer鈥檚 drug development by region 2025
Worldwide
Clinical phase Alzheimer鈥檚 disease drugs 2025, by sponsor
Worldwide
Phase 3 Alzheimer's drugs in development July 2019, by mechanism of action
USA
Number of active disease-modifying Alzheimer's drug trials globally in 2019, by phase
Worldwide
Number Alzheimer's drug trials globally in 2019, by category and phase
Worldwide
Alzheimer's disease clinical trials success rate globally from 2008-2019, by phase
Worldwide
Alzheimer's disease clinical trials with select modalities worldwide as of 2019
Worldwide
Alzheimer's disease clinical trials started worldwide from 2008-2017, by phase
Worldwide
Share of active trials for Alzheimer's Disease pipeline 2022, by product type
Worldwide
Key technologies in Alzheimer's Disease clinical trials 2021
Worldwide
Number of active trials in Alzheimer's Disease pipeline 2022, by product type
Worldwide
Pharmaceutical companies with Alzheimer's drugs in development 2019
Worldwide
Share of registered global clinical trials by phase 2025
Worldwide
Distribution of older people in the U.S. population with Alzheimer鈥檚 2050
USA
Mechanism of action in oncology pipeline worldwide 2023
Worldwide
Cell and gene therapy clinical trials in development worldwide 2019, by trial phase
Worldwide
Number of unsuccessful Alzheimer鈥檚 drugs in development in the U.S. 1998-2017
USA
Share of global clinical trials as of March 2025, by intervention type
Worldwide
ATMP trials classification share by disease and development phase globally 2016
Worldwide
Share of trials in top therapeutic areas started worldwide in 2023, by phase
Worldwide
Projected numbers of older people with Alzheimer's in the U.S. 2020-2060
USA
Percentage of elderly people with Alzheimer's disease in the United States 2015-2050
USA
Alzheimer's amongst older people in 2050: impact of a 5-year delay in onset
USA
Projected annual Medicare & Medicaid spending on Alzheimer's 2010-2050
USA
Global AI-enabled drug discovery and clinical trials market by region 2030
Worldwide
Clinical drug trials started worldwide 2018-2023, by key therapeutic area
Worldwide
Biopharmaceutical drugs in Germany 2008-2024, by stage of development
DEU
Type 2 diabetes clinical pipeline in the U.S. in 2018, by type and phase
USA
Share of global clinical trials for rare diseases from 2010 to 2016, by modality
Worldwide
Global ongoing regenerative medicine clinical trials by phase and sponsor Q2 2024
Worldwide
United States - spending on Alzheimer patients
USA
Distribution of U.S. care costs for older people with Alzheimer 2011-2025 by payer
USA
Clinical trials initiated worldwide 2018-2024, by trial phase
Worldwide
Share of releases on AI in drug discovery worldwide by therapy area 2018-2022
Worldwide
Type 2 diabetes clinical trial success rates U.S. 2006-2015, by phase and indication
USA
Clinical studies in Mexico 2025, by phase
MEX
Global active regenerative medicine clinical trials by approach Q2 2024
Worldwide
Obesity drugs clinical pipeline U.S. 2018, by type and phase
USA
Clinical trial starts for novel heart failure drugs U.S. 2009-2018, by stage
USA
COVID-19 clinical studies in Mexico 2025, by phase
MEX
Alzheimer's in the U.S: lifetime risks, by age and gender
USA
AI in the pharmaceutical industry
Worldwide
Clinical trials 鈥 statistics & facts
Worldwide
Clinical trials
Worldwide
AI in the pharmaceutical industry 鈥 statistics & facts
Worldwide
Dementia and Alzheimer's disease in Europe
We鈥檙e happy to help

Get in touch with us for additional information

Feel free to contact us anytime. We will respond to your inquiry as quickly as possible.

Get in touch